STATISTICAL METHODS IN MEDICAL RESEARCH is a leading academic journal dedicated to advancing the field of statistical methodologies as they apply to medical research. Published by SAGE Publications Ltd, this prestigious journal focuses on innovative statistical techniques that are pivotal for health-related data analysis and interpretation. With its Q1 ranking in Epidemiology, Health Information Management, and Statistics and Probability as of 2023, it stands out as a vital resource for researchers and practitioners alike. The journal, which has been in circulation since 1992, is widely recognized for its robust contributions to evidence-based medicine and public health, ensuring that practitioners have access to cutting-edge research. Although it currently does not offer Open Access options, the high-impact nature indicated by its rankings and percentile positions solidifies its importance as a go-to source for statistical theories and applications in health research. Researchers, healthcare professionals, and students are encouraged to explore the rich content of this journal to stay abreast of the latest advancements and methodologies.

Clinical Pharmacology in Drug Development, published by WILEY, is a distinguished journal dedicated to advancing the field of pharmaceutical science and drug development. With a strong commitment to disseminating cutting-edge research, this journal serves as a crucial platform for professionals, researchers, and students aiming to enhance their understanding of pharmacological principles and innovations in medical therapeutics. Since its inception in 2012, the journal has consistently maintained a noteworthy presence in the academic community, currently achieving a Q2 ranking in both Pharmaceutical Science and Medical Pharmacology categories as of 2023. Although the journal operates under a subscription model, it is highly regarded for its rigorous peer-reviewed publications, offering insights into drug efficacy, safety, and regulatory challenges. Positioned at the intersection of clinical practices and pharmaceutical advancements, Clinical Pharmacology in Drug Development plays an essential role in bridging the gap between scientific research and real-world application, ensuring that the latest therapeutic strategies are optimized for patient care.

ART JOURNAL, published by Taylor & Francis Inc, is a distinguished journal in the field of Visual Arts and Performing Arts, boasting a commendable Q2 ranking in the latest 2023 category quartiles. With an ISSN of 0004-3249 and E-ISSN 2325-5307, this journal has been a vital platform for artistic discourse since its inception in 1960, detailing a rich lineage of research from 1960 to 1985 and from 1987 to the present. Acknowledged for its pedagogical value and scholarly contributions, the ART JOURNAL ranks #220 out of 667 in the Scopus database, placing it in the 67th percentile among its peers. Despite not currently providing open access options, the journal remains an invaluable resource for researchers, professionals, and students in the arts, fostering an environment for innovative thought and stimulating scholarly exchange.

Field Methods, an esteemed journal published by SAGE Publications Inc, specializes in the realm of Anthropology, presenting innovative research methodologies that shape contemporary anthropological inquiry. With an impressive impact factor reflected in its 2023 Scopus ranking as #81 out of 502 in the field of Social Sciences, this Q1 journal serves as a critical platform for academics, professionals, and students committed to advancing ethnographic research and methodological discourse. The journal, established in 1989, has embraced an interdisciplinary approach, encouraging submissions that explore both qualitative and quantitative methods across diverse contexts. While access options are not open access, subscribers benefit from comprehensive insights into the methodologies that underpin anthropological studies. As Field Methods approaches its converged years until 2024, it continues to play a pivotal role in informing and inspiring the next generation of scholars and practitioners aiming to enrich our understanding of cultures and communities worldwide.

Journal of EMDR Practice and Research, published by Springer Publishing Co, is an essential resource for professionals in the field of psychology and mental health, focusing specifically on Eye Movement Desensitization and Reprocessing (EMDR) therapy. Established in 2010, the journal spans a significant academic horizon, aiming to disseminate high-quality research and practical applications of EMDR in clinical settings. With an increasing scope that intersects with Biological Psychiatry, Cognitive Neuroscience, and Neuropsychology, the journal occupies an important niche evidenced by its latest Scopus rankings, including a Q3 classification in Experimental and Cognitive Psychology. Researchers and clinicians benefit from access to emerging findings that can inform their practices, ultimately improving the treatment outcomes for individuals facing trauma and related disorders. Although specific open access options may not be available, the journal remains committed to upholding high standards of scholarly contribution in the realm of mental health.

PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

The International Journal of Biostatistics, published by Walter de Gruyter GmbH, stands as a critical platform for advancements in the fields of biostatistics and applied statistics in medicine. With an ISSN of 2194-573X and an E-ISSN of 1557-4679, this journal has gained recognition for its rigorous peer-reviewed articles that bridge theoretical statistics and its practical applications in health sciences, maintaining a commendable Q2 quartile ranking in both Medicine and Statistics categories as of 2023. Hosted in Germany, the journal's pivotal role lies in disseminating innovative research findings that guide public health decisions and inform healthcare policy, thus appealing to a diverse readership including researchers, healthcare professionals, and students. Although the journal operates under a subscription model, it remains committed to providing valuable insights into the statistical methods that support evidence-based medicine and improve health outcomes globally. For those engaged in the evolving landscape of biostatistics, the International Journal of Biostatistics serves as an indispensable resource through its comprehensive coverage from 2005 to 2024.

Clinical Trials, published by SAGE Publications Ltd, is a prestigious journal that serves as a vital resource for researchers, professionals, and students in the fields of medicine and pharmacology. Operating since 2004 and converging through 2024, this journal boasts an impressive standing in the academic community, achieving a Q1 categorization in both Medicine (miscellaneous) and Pharmacology as of 2023. The journal's Scopus rankings reflect its influential contributions, with a rank of #128 out of 636 in General Medicine and a 79th percentile placement, alongside a rank of #172 out of 313 in Pharmacology, indicating its significant role in advancing clinical research. Based in the United Kingdom, Clinical Trials focuses on disseminating high-quality studies that enhance the understanding of clinical processes and therapeutic methodologies. Although it does not currently offer Open Access, the journal provides a platform for traditional publication, ensuring the dissemination of critical knowledge in the healthcare domain.

BMJ Evidence-Based Medicine is a premier journal published by BMJ Publishing Group that focuses on the critical appraisal and application of scientific evidence in clinical practice. With its ISSN 2515-446X and E-ISSN 2515-4478, this impactful journal operates out of the United Kingdom and has established itself as a leading resource in the field of evidence-based medicine, reflected by its impressive Q1 ranking in the Medicine (miscellaneous) category and a significant 93rd percentile ranking amongst General Medicine titles on Scopus. Offering an essential platform for researchers, practitioners, and students alike, the journal disseminates high-quality research and reviews that significantly influence healthcare practices worldwide. The journal currently has access options available for readers through institutional subscriptions and individual licenses, making cutting-edge research easily accessible to those dedicated to advancing medical knowledge. With its commitment to evidence-based practice, BMJ Evidence-Based Medicine plays a crucial role in improving patient outcomes and informing clinical decisions.

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.